The Oncology Institute, Inc.
TOI
$2.96
-$0.14-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.61M | -66.28M | -65.89M | -64.36M | -64.66M |
| Total Depreciation and Amortization | 6.94M | 7.02M | 6.87M | 6.58M | 6.29M |
| Total Amortization of Deferred Charges | 8.38M | 8.77M | 9.18M | 9.62M | 6.31M |
| Total Other Non-Cash Items | 19.37M | 20.45M | 15.61M | 8.59M | 7.47M |
| Change in Net Operating Assets | 1.33M | 6.41M | 24.04M | 23.92M | 18.06M |
| Cash from Operations | -24.59M | -23.63M | -10.19M | -15.64M | -26.54M |
| Capital Expenditure | -3.20M | -3.90M | -2.89M | -3.51M | -3.79M |
| Sale of Property, Plant, and Equipment | 126.00K | 126.00K | 126.00K | 126.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 10.00M | 30.00M | 50.00M |
| Cash from Investing | -3.07M | -3.77M | 7.24M | 26.62M | 46.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -21.03M | -20.88M | -20.65M | -20.42M | -1.20M |
| Issuance of Common Stock | 32.64M | 28.54M | 17.70M | 15.50M | 75.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | 0.00 | -232.00K | -2.37M | -2.37M |
| Cash from Financing | 11.56M | 7.66M | -3.18M | -7.29M | -3.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.10M | -19.74M | -6.13M | 3.68M | 16.18M |